(1)
Bladder Cancer Diagnosis and Monitoring Based on Urine Survivin (BIRC5) Bioluminescence-Based Immunoassay. Вопр. онкол. 2026, 72 (2), OF-2510. https://doi.org/10.37469/0507-3758-2026-72-2-OF-2510.